Annual Report. Coalition interagence sida et développement. Interagency Coalition on AIDS and Development 1 APRIL 2009 TO 3 1 M A R C H

Transcription

1 Interagency Coalition on AIDS and Development Coalition interagence sida et développement Annual Report 1 APRIL 2009 TO 3 1 M A R C H ICAD Annual Report

2 TABLE OF CONTENTS Mission... 3 Vision... 3 Mandate... 3 Values... 3 Message from the ICAD Board President... 4 Message from the ICAD Executive Director... 4 Activities... 5 Publications... 5 Conference Presentations and Posters... 5 ICAD Events and Workshops... 6 Webinars (Virtual Seminars)... 6 Engaging Members... 6 Projects and Partnerships... 7 Public Engagement... 7 Media... 7 Statement of Financial Position... 8 Statement of Revenues and Expenses... 9 Staff April March Board of Directors April March Acknowledgements ICAD Annual Report

3 MISSION The Interagency Coalition on AIDS and Development (ICAD) provides leadership in the response of Canadian international development organizations and Canadian HIV organizations in reducing the impact of the global HIV and AIDS epidemic. ICAD does this through improving public policy, providing information and analysis, and sharing lessons learned. VISION The vision of ICAD is a world where the stigma, discrimination and inequities that drive HIV infection are eliminated and people living with or vulnerable to HIV infection are resourced and supported. MANDATE ICAD pursues its mission by: Improving public policy: ICAD conducts research and analysis, convenes stakeholders and provides expert advice to promote and enhance policy dialogue in Canada s response to the global HIV epidemic. Providing information and analysis: ICAD develops or identifies educational tools and resource materials to help members, the public and stakeholders in HIV, international development and government organizations understand and act upon important issues in the global HIV epidemic and in Canada s response. Sharing lessons learned: ICAD strengthens the capacity of various stakeholders, including its members and governments, to address the global HIV epidemic by sharing lessons learned on programs and partnerships. VALUES As with all progressive organizations working in the field of HIV/AIDS, ICAD is guided by the human development principles of human rights, gender equity and the greater involvement of people living with HIV/AIDS (GIPA) and groups most vulnerable to HIV infection. ICAD holds that a human rights approach to the HIV/ AIDS epidemic moves beyond a focus on the individual to address social, economic and political factors that drive the epidemic, such as gender-based inequities, poverty, corruption and government inaction. A rights-based approach empowers affected individuals and communities, and challenges governments to justify their actions (or inaction) to the people they represent and, ultimately, to the global community. A gender equity analysis means that programming takes into consideration gender roles and responsibilities, and women s vulnerability to HIV/AIDS because of systemic discrimination, sexual violence and the economic, social and political inequities, and gender inequities. A genderbased approach acknowledges the need to engage men and boys in addressing gender inequities. ICAD also views the HIV epidemic within the broader context of overall human development, and not solely as a medical or health issue. Vulnerability to HIV/AIDS and its impact on an individual or community are closely associated with, and exacerbated by, the wider challenges to development such as poverty, food and livelihood insecurity, and gender inequity. A holistic approach to programming is needed in order to address the effects of the pandemic, particularly on marginalized communities. ICAD s constitution and bylaws stipulate that at least one Board position be reserved for a person living with HIV/ AIDS. ICAD works closely with the ICAD membership to ensure that the priorities and concerns of people living with HIV/AIDS are effectively considered and integrated into ICAD s policies and decision-making processes. ICAD is an equal opportunity employer and actively recruits not only Board members but also staff and volunteers who are living with HIV/AIDS. ICAD Annual Report

4 MESSAGE FROM THE ICAD BOARD PRESIDENT Once again this has been a year of change, challenges and accomplishments for ICAD. The organization has drafted a new strategic plan to ensure ICAD remains relevant within the evolving world of HIV, and crucially, to our members. We have an updated and more interactive website. The difficult times for many NGOs have made it clear how important it is that Canadian HIV organisations have a strong and inclusive voice. ICAD has continued to support us being heard. It has, again, brought together and shared among us domestic and international best practices in HIV. Internally, Nicci Stein completed her first year as Executive Director. Unfortunately a couple of Board members needed to resign mid-term - Rosine Assemoi and Chantelle MacDonald. There have been a few staffing changes but as usual ICAD has been able to recruit talent, albeit while regretting the loss of those who have given so much to the organization. I remain impressed by ICAD s staff, Board members and wider membership, all of whom are knowledgeable, committed and incredibly hard working. It has been a privilege for me to serve as ICAD President this year. I look forward to working with you all again next year. Michelle Munro, Board President MESSAGE FROM THE EXECUTIVE DIRECTOR recall that it wasn t long into my new job at ICAD that I realized that 2009/2010 was going to I be a busy year, inspired by a collection of some unique moments in time that offered unprecedented challenges and opportunities - the G8 and G20 Summits, the International AIDS Conference in Vienna, the MDG Summit and the Global Fund Replenishment conference. Even before I started at ICAD, the organization had been involved in civil society organizing for the G8 Summit but this time, as host country, we took leadership and worked hard to forge stronger ties with other civil society players in Canada and abroad, as well as with the government. As the list of activities below demonstrates, ICAD has had a remarkable year of achievements and I commend the excellent staff team, consultants and member organisations who helped us reach our ambitious goals. The Board of Directors has been a wonderful source of support and wisdom for both me and the organization as a whole. The Board led us through a Strategic Planning process this year, producing a plan that is ambitious but realistic and offers focus and clarity to our future areas of work. For me, the highlight of this plan is working to increase the active engagement of members in our work. This year we also focused on building a resource development strategy. We have worked hard to develop the website, which now has easier navigation and a fresh design. We moved to e-newsletters instead of hard copies and condensed the many interesting news articles and announcements into a weekly news digest. We continued to develop excellent and informative educational resources and opportunities for our members. We have continued our partnerships with IPM and IAVI and have also enhanced this work through additional programming funded through the Canadian HIV Vaccine Initiative (CHVI). All in all, an active and exciting year! Nicci Stein, Executive Director 4 ICAD Annual Report

5 ACTIVITIES Publications Broader Determinants of Health in an Aboriginal Context April 2009 Health Systems and HIV: Priorities for Civil Society Advocacy April 2009 Hepatitis C and HIV April 2009 Prevention Programs in Developed Countries: Lessons Learned August 2009 World AIDS Day Newsletter December 2009 PrEP as a Potential HIV Prevention Method January 2010 Tools, Trends and New Technologies in HIV Prevention update January 2010 TB/HIV Co-infection March 2010 Quarterly e-newsletters CD resources on new HIV prevention technologies Conference Presentations and Posters 18th Annual Canadian Association of HIV Researchers (CAHR) conference, May 2009, Vancouver. Satellite session Comprehensive HIV Prevention, Microbicides and the Canadian Microbicides Action Plan (CMAP) co-hosted with Canadian AIDS Society (CAS). Canadian Conference on International Health, October 2009, Ottawa. Session with Dr David Kihumuro Apuuli Science as Global Health Diplomacy (in partnership with IAVI) Canadian Conference on International Health, October 2009, Ottawa. Presentation Accountability for the MDGs: Keeping health on the G8 agenda Canadian Conference on International Health, October 2009, Ottawa. Presentation The 2010 G8 Muskoka Summit: An Agenda for Development Ontario HIV Treatment Network conference, November 2009, Toronto. Poster The Impact of AIDS vaccine Research on Health Systems Strengthening Ontario HIV Treatment Network conference, November 2009, Toronto. Poster HIV Prevention and the African and Caribbean Diaspora Ontario HIV Treatment Network conference, November 2009, Toronto. HIV/AIDS and the Broader Determinants of Health in an Aboriginal Context Canadian AIDS Society (CAS) Skills Building Symposium, Montreal, March Satellite session HIV Vaccine Preparedness and New HIV Prevention Technologies, in partnership with Canadian AIDS Society, Canadian AIDS Treatment Information Exchange, and Coalition des organismes Québécois de lutte contre le sida. Canadian AIDS Society (CAS) Skills Building Symposium, Montreal, March Workshop What Makes a Network Work? Canadian AIDS Society (CAS) Skills Building Symposium, Montreal, March Workshop Regional Activities Leading up to the AIDS Conference in Vienna Canadian AIDS Society (CAS) Skills Building Symposium, Montreal, March Workshop Canada s Country UNGASS Report: what it is and how to use it with Tanya Lary (PHAC) and Evan Collins. Canadian AIDS Society (CAS) Skills Building Symposium, Montreal, March Workshop Global Health Initiatives and HIV/AIDS: Current Issues in Global Health and the Role of Civil Society with Evan Collins. Canadian AIDS Society (CAS) Skills Building Symposium, Montreal, March Presentation at International plenary session. ICAD Annual Report

6 2009 ICAD Annual General Meeting ICAD Events and Workshops Pre-Exposure Prophylaxis as a Potential HIV Prevention Method: Building Awareness and Action among Canadians November 2009, Ottawa. New HIV Prevention Technologies workshops. March 2010, Halifax (in partnership with AIDS Coalition of Nova Scotia and Oxfam Canada - Maritimes; Toronto (in partnership with AIDS Committee of Toronto); Ottawa (in partnership with the Department of Health Promotion at the University of Ottawa). In Women s Hands: Microbicides as a Female-Initiated HIV Prevention Tool December 2009, Ottawa. Cohosted with Canadian Association of Parliamentarians on Population and Development, Action Canada for Population and Development, Canadian AIDS Society and Global Campaign for Microbicides. Meeting the Challenge: HIV prevention and the African and Caribbean Diaspora September 2009 (in partnership with ACCHO and in conjunction with the ICAD Annual General Meeting). Science and Technology and an International Development Strategy: The Global AIDS Vaccine Effort public forum with Dr Apuuli (Director General of the Uganda AIDS Commission). Co-sponsored with IAVI, Canadian AIDS Society and the University of Ottawa s Institute for Population Health and Centre for International Policy Studies. Webinars (Virtual Seminars) Health Systems and HIV: Priorities for Civil Society Advocacy June 2009 presented by Michelle Munro. Preparing Abstracts for AIDS 2010 in Vienna January 2010 presented by John Miller. Science and Technology and an International Development Strategy: The Global AIDS Vaccine Effort October presented by Dr David Kihumuro Apuuli (Director General of the Uganda AIDS Commission). Co-hosted with IAVI (International AIDS Vaccine Initiative). Engaging Members UNAIDS Programme Coordinating Board: ICAD hosts teleconferences with CIDA reps and civil society before and after each PCB meeting Global Fund Board: ICAD hosts teleconferences with CIDA reps and civil society before and after each Board meeting GTAG Global Treatment Access Group (co-hosted with other members of the group) H1N1 consultation with ICAD members to feed into PHAC consultation and development of HIV-specific materials. 6 ICAD Annual Report

7 Projects and Partnerships Building Community Engagement in Vaccines in Africa and Canada in partnership with Southern Africa AIDS Trust (Zimbabwe) and New HIV Vaccine and Microbicide Advocacy Society (Nigeria). Funded by Canadian HIV Vaccines Initiative (CHVI). International Partnership on Microbicides International AIDS Vaccine Initiative ICAD participated in the Civil G8 Dialogue in Rome in June G8 Civil Society Coordinating Committee and Steering Committee Global Fund resource development and replenishment (International Civil Society Support, Amsterdam) International Affairs Directorate (Health Canada) Consultative Group Canadian Microbicides Action Plan (CMAP) Implementation Committee (in partnership with the Canadian AIDS Society) Public Engagement ICAD organized an NGO fair in the CIDA lobby on World AIDS Day ICAD supported the following campaigns: Reforming Canada s Access to Medicines Regime (CAMR) Canadian and African Unions Days of Action preceding the 2010 G8 and G20 meetings At the Table Canadian civil society public engagement campaign leading up to the 2010 G8 and G20 meetings Media On the Path to an AIDS Vaccine World AIDS Vaccine Day op-ed in National Post May Written by ICAD, International AIDS Vaccine Initiative (IAVI), International Council of AIDS Service Organisations (ICASO) and Canadian AIDS Society (CAS). Leading Together: What we can do to overcome AIDS at home and abroad - op-ed in Hill Times January Written by ICAD, Canadian AIDS Society (CAS), Canadian AIDS Treatment Information Exchange (CATIE), Canadian Association for HIV Research (CAHR), Canadian HIV/AIDS Legal Network, and Canadian Treatment Action Council (CTAC). ICAD calls for action on HIV and AIDS as part of the G8 maternal and child health initiative - press release February Supporting labour unions campaign for universal access to HIV prevention, treatment, care and support. ICAD Annual Report

8 STATEMENT OF FINANCIAL POSITION March ASSETS CURRENT ASSETS Cash and short-term investments 204, ,457 Accounts receivable 80,182 13,354 Prepaid expenses 5,764 16,042 90, ,853 CAPITAL ASSETS 7,698 9, , ,459 LIABILITIES AND NET ASSETS CURRENT LIABILITIES Accounts payable and accrued liabilities 60,919 47,732 Deferred revenue 52,187 72, , ,796 NET ASSETS Investment in capital assets 7,698 9,606 Unrestricted 177, , , , , ,459 8 ICAD Annual Report

9 STATEMENT OF REVENUES AND EXPENSES Year Ended March Revenues Public Health Agency of Canada 456, ,262 Public Health Agency of Canada - CHVI 76,792 - Health Canada - International Health Grants 37,833 - Canadian International Development Agency 23, ,643 International Partnership for Microbicides 61,459 29,747 International AIDS Vaccine Initiative 29,477 16,405 ViiV Healthcare in Partnership with Shire Canada 13,000 - Canadian Institutes of Health Research 9,900 - Ontario HIV Treatment Network 6,500 - Canadian Society for International Health - 52,915 Memberships 12,960 15,080 Other 13,411 12, , ,234 Program Expenses (Schedule) Public Health Agency of Canada 533, ,262 Health Canada 37,833 - Canadian International Development Agency 23, ,393 Other 126, , , ,288 19,738 11,946 Strategic Review (10,217) - EXCESS OF REVENUES OVER EXPENSES 9,521 11,946 ICAD Annual Report

10 STAFF APRIL 2009 MARCH 2010 Kate Alexander Administrative Officer Shayna Buhler Program Officer Rosemary Forbes Program Manager Angeline Jones Program Officer Francisca Sousa Financial Analyst Nicci Stein Executive Director BOARD OF DIRECTORS APRIL MARCH 2010 Michelle Munro (President) Private consultant; Ottawa, Ontario Chantelle MacDonald (resigned February 2010) AIDS Coalition of Nova Scotia; Halifax, Nova Scotia Evan Collins (Vice-President) Private consultant; Toronto, Ontario Brent Oliver Private Consultant; Calgary, Alberta Joan Campbell (Treasurer) Canadian Crossroads International; Halifax, Nova Scotia Tricia Smith CATIE; Toronto, Ontario Rosine Assamoi (Secretary) Save the Children Canada; Toronto, Ontario (resigned September 2009) Anna Callegari (resigned August 2009) Salt Spring Organisation for Life Improvement and Development (SOLID); Victoria, British Columbia Debra Jakubec HIV Network of Edmonton Society; Edmonton, Alberta Sian Fitzgerald (term ended 2009) Healthbridge Foundation of Canada; Ottawa, Ontario Fran Keough AIDS Committee of Newfoundland and Labrador; St John s, Newfoundland Judy Mill (term ended 2009) University of Alberta; Edmonton, Alberta 10 ICAD Annual Report

11 ACKNOWLEDGEMENTS ICAD would like to acknowledge and thank: The Public Health Agency of Canada (PHAC), Health Canada International Affairs Directorate, the Canadian International Development Agency (CIDA), the International Partnership on Microbicides (IPM), the International AIDS Vaccine Initiative (IAVI), Industrial Alliance Insurance and Financial Services Inc. and ViiV Healthcare and GlaxoSmithKline in Partnership with Shire Canada for their support. ICAD would also like to thank the following consultants who contributed to our work this year: Marlene Laroque, Michelle Munro, San Patten, Marc-André Leblanc, Keisa Campbell, Jean Dussault, Josée Dussault, Micheline Laflamme, Artem Lavrenkov, Dionne A. Falconer, Glen Brown, Anthony Micelli, Harold Sikkema, John Miller, Glenn Betteridge, Lia De Pauw, and Nancy Cooper. ICAD Annual Report

12 CONTACT ICAD 1 Nicholas Street, Suite 726 Ottawa ON K1N 7B7 Telephone: (613) Fax: (613) info@icad-cisd.com Web: